<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Kidney_Stones.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:30 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1228000">
<meta name="Category" content="Concern">
<meta name="Article" content="Kidney_Stones">
<title>C&#225;lculos Renales-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">C&#225;lculos Renales</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Kidney_Stones.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Blacklock N. Renal stone. In: <em>Western Diseases: Their Emergence and
Prevention</em>, ed. DP Burkitt and HC Trowell. Cambridge, MA: Harvard Press, 1981,
60&#8211;70.</li>

<li class="Ref">Massey LK, Roman-Smith H, Sutton RAL. Effect of dietary oxalate and calcium on
urinary oxalate and risk of formation of calcium oxalate kidney stones. <em>J Am Dietet
Assoc</em> 1993;93:901&#8211;6.</li>

<li class="Ref">Massey LK, Roman-Smith H, Sutton RAL. Effect of dietary oxalate and calcium on
urinary oxalate and risk of formation of calcium oxalate kidney stones. <em>J Am Dietet
Assoc</em>1993;93:901&#8211;6.</li>

<li class="Ref">Brinkley L, McGuire J, Gregory J, Pak CYC, et al. Bioavailability of oxalate
in foods. <em>Urology</em> 1981;17:534.</li>

<li class="Ref">Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A Prospective study of dietary
calcium and other nutrients and the risk of symptomatic kidney stones. <em>N Engl J Med</em>
1993;328:833&#8211;8.</li>

<li class="Ref">Hassapidou MN, Paraskevopoulos S Th, Karakoltsidis PA, et al. Dietary habits
of patients with renal stone disease in Greece. <em>J Human Nutr Dietet</em>
1999;12:47&#8211;51.</li>

<li class="Ref">Hughes J, Norman RW. Diet and calcium stones. <em>Can Med Assoc J</em>
1992;146:137&#8211;43 [review].</li>

<li class="Ref">Hassapidou MN, Paraskevopoulos ST, Karakoltsidis PA, et al. Dietary habits of
patients with renal stone disease in Greece. <em>J Human Nutr Dietet</em>
1999;12:47&#8211;51.</li>

<li class="Ref">Robertson WG, Peacock M, Marshall DH. Prevalence of urinary stone disease in
vegetarians. <em>Eur Urol</em> 1982;8:334&#8211;9.</li>

<li class="Ref">Hiatt RA, Ettinger B, Caan B, et al. Randomized controlled trial of a low
animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones.
<em>Am J Epidemiol</em> 1996;144:25&#8211;33.</li>

<li class="Ref">Hughes J, Norman RW. Diet and calcium stones. <em>Can Med Assoc J</em>
1992;146:137&#8211;43 [review].</li>

<li class="Ref">Hassapidou MN, Paraskevopoulos ST, Karakoltsidis PA, et al. Dietary habits of
patients with renal stone disease in Greece. <em>J Human Nutr Dietet</em>
1999;12:47&#8211;51.</li>

<li class="Ref">Martini LA, Wood RJ. Should dietary calcium and protein be restricted in
patients with nephrolithiasis? <em>Nutr Rev</em> 2000;58:111&#8211;7 [review].</li>

<li class="Ref">Rao PN, Prendiville V, Buxton A, et al. Dietary management of urinary risk
factors in renal stone formers. <em>Br J Urol</em> 1982;54:578&#8211;83.</li>

<li class="Ref">Giannini S, Nobile M, Sartori L, et al. Acute effects of moderate dietary
protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis.
<em>Am J Clin Nutr</em> 1999;69:267&#8211;71.</li>

<li class="Ref">Muldowney FP, Freaney R, Moloney MF. Importance of dietary sodium in the
hypercalciuria syndrome. <em>Kidney Int</em> 1982;22:292&#8211;6.</li>

<li class="Ref">Sabto J, Powell MJ, Gurr B, Gurr FW. Influence of urinary sodium on calcium
excretion in normal individuals. <em>Med J Austral</em> 1984;140:354&#8211;6.</li>

<li class="Ref">Silver J, Rubinger D, Friedlaender MM, Popovitzer MM. Sodium-dependent
idiopathic hypercalciuria in renal-stone formers. <em>Lancet</em> 1983;ii:484&#8211;6.</li>

<li class="Ref">Massey LK, Whiting SJ. Dietary salt, urinary calcium, and kidney stone risk.
<em>Nutr Rev</em> 1995;131&#8211;9 [review].</li>

<li class="Ref">Hughes J, Norman RW. Diet and calcium stones. <em>Can Med Assoc J</em>
1992;146:137&#8211;43 [review].</li>

<li class="Ref">Sakhaee K, Harvey JA, Padalino PK, et al. The potential role of salt abuse on
the risk for kidney stone formation. <em>J Urol</em> 1993;150(2 pt1):310&#8211;2.</li>

<li class="Ref">Lehman J Jr, Pleuss JA, Gray RW, Hoffman RG. Potassium administration
increases and potassium deprivation reduces urinary calcium excretion in healthy adults. <em>
Kidney Int</em> 1991;39:973&#8211;83.</li>

<li class="Ref">Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary
calcium and other nutrients and the risk of symptomatic kidney stones. <em>N Engl J Med</em>
1993;328:833&#8211;8.</li>

<li class="Ref">Lee YH, Huang WC, Tsai JY, Huang JK. The efficacy of potassium citrate based
medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study.
<em>J Urol</em> 1999;161:1453&#8211;7.</li>

<li class="Ref">Breslau NA, Padalino P, Kok DJ, et al. Physicochemical effects of a new
slow-release potassium phosphate preparation (UroPhos-K) in absorptive hypercalciuria. <em>J
Bone Miner Res</em> 1995;10:394&#8211;400.</li>

<li class="Ref">Ettinger B, Pak CY, Citron JT, et al. Potassium-magnesium citrate is an
effective prophylaxis against recurrent calcium oxalate nephrolithiasis. <em>J Urol</em>
1997;158:2069&#8211;73.</li>

<li class="Ref">Pak CY. Medical prevention of renal stone disease. <em>Nephron</em>
1999;81(Suppl 1):60&#8211;5 [review].</li>

<li class="Ref">Pak CY. Nephrolithiasis from calcium supplementation. J Urol
1987;137:1212&#8211;3 [editorial].</li>

<li class="Ref">Levine BS, Rodman JS, Wienerman S, et al. Effect of calcium citrate
supplementation on urinary calcium oxalate saturation in female stone formers: implications
for prevention of osteoporosis. <em>Am J Clin Nutr</em> 1994;60:592&#8211;6.</li>

<li class="Ref">Seltzer MA, Low RK, McDonald M, et al. Dietary manipulation with lemonade to
treat hypocitraturic calcium nephrolithiasis. <em>J Urol</em> 1996;156:907&#8211;9.</li>

<li class="Ref">Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for
kidney stones in women. <em>Ann Intern Med</em> 1998;128:534&#8211;40.</li>

<li class="Ref">Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and
the risk of kidney stones. <em>Am J Epidemiol</em> 1996;143:240&#8211;7.</li>

<li class="Ref">Shah PJR. Unprocessed bran and its effect on urinary calcium excretion in
idiopathic hypercalciuria. <em>Br Med J</em> 1980;281:426.</li>

<li class="Ref">Ebisuno S, Morimoto S, Yoshida T, et al. Rice-bran treatment for calcium stone
formers with idiopathic hypercalciuria. <em>Brit J Urol</em> 1986;58:592&#8211;5.</li>

<li class="Ref">Rao PN, Gordon C, Davies D, Blacklock NJ. Are stone formers maladapted to
refined carbohydrates? <em>Br J Urol</em> 1982;54:575&#8211;7.</li>

<li class="Ref">Li MK, Kavanagh JP, Prendiville V, et al. Does sucrose damage kidneys? <em>Br
J Urol</em> 1986;58:353&#8211;7.</li>

<li class="Ref">Lemann J Jr, Piering WF, Lennon EJ. Possible role of carbohydrate-induced
calciuria in calcium oxalate kidney-stone formation. <em>N Engl J Med</em>
1969;280:232&#8211;7.</li>

<li class="Ref">Gaby AR. Commentary. <em>Nutr Healing</em> 1996;Jan:1,10&#8211;1.</li>

<li class="Ref">Piesse JW. Nutritional factors in calcium containing kidney stones with
particular emphasis on vitamin C. <em>Int Clin Nutr Rev</em> 1985;5:110&#8211;29
[review].</li>

<li class="Ref">Robertson WG, Peacock M, Heyburn PJ, Hanes FA. Epidemiological risk factors in
calcium stone disease. <em>Scand J Urol Nephrol Supplement</em> 1980;53:15&#8211;30.</li>

<li class="Ref">Hollingbery PW, Massey LK. Effect of dietary caffeine and sucrose on urinary
calcium excretion in adolescents. <em>Fed Proc</em> 1986;45:375 [abstr #1280].</li>

<li class="Ref">Kiel DP, Felson DT, Hannan MT, et al. Caffeine and the risk of hip fracture:
the Framingham study. <em>Am J Epidemiol</em> 1990;132:675&#8211;84.</li>

<li class="Ref">Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and
the risk of kidney stones. <em>Am J Epidemiol</em> 1996;143:240&#8211;7.</li>

<li class="Ref">Shuster J, Finlayson B, Scheaffer RL, et al. Primary liquid intake and urinary
stone disease. <em>J Chron Dis</em> 1985;38:907&#8211;14.</li>

<li class="Ref">Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for
kidney stones in women. <em>Ann Intern Med</em> 1998;128:534&#8211;40.</li>

<li class="Ref">Shuster J, Finlayson B, Scheaffer RL, et al. Primary liquid intake and urinary
stone disease. <em>J Chron Dis</em> 1985;38:907&#8211;14.</li>

<li class="Ref">Shuster J, Jenkins A, Logan C, et al. Soft drink consumption and urinary stone
recurrence: a randomized prevention trial. <em>J Clin Epidemiol</em> 1992;45:911&#8211;6.</li>

<li class="Ref">Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and
the risk of kidney stones. <em>Am J Epidemiol</em> 1996;143:240&#8211;7.</li>

<li class="Ref">Conte A, Piz&#225; P, Garcia-Raja A, et al. Urinary lithogen risk test:
usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors
(citrate and phytate). <em>Arch Esp Urol</em> 1999;52:305&#8211;10.</li>

<li class="Ref">Grases F, Costa-Bauza A. Phytate (IP6) is a powerful agent for preventing
calcifications in biological fluids: usefulness in renal lithiasis treatment. <em>Anticancer
Res</em> 1999;19:3717&#8211;22.</li>

<li class="Ref">Marshall RW, Cochran M, Hodgkinson A. Relationship between calcium and oxalic
acid intake in the diet and their excretion in the urine of normal and renal-stone forming
subjects. <em>Clin Sci</em> 1972;43:91&#8211;9.</li>

<li class="Ref">Lemann J Jr. Composition of the diet and calcium kidney stones. <em>N Engl J
Med</em> 1993;328:880&#8211;2 [editorial].</li>

<li class="Ref">Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary
calcium and other nutrients and the risk of symptomatic kidney stones. <em>N Engl J Med</em>
1993;328:833&#8211;8.</li>

<li class="Ref">Hassapidou MN, Paraskevopoulos S Th, Karakoltsidis PA, et al. Dietary habits
of patients with renal stone disease in Greece. <em>J Human Nutr Dietet</em>
1999;12:47&#8211;51.</li>

<li class="Ref">Sowers MFR, Hannausch M, Wood C, et al. Prevalence of renal stones in a
population-based study with dietary calcium, oxalate, and medication exposures. <em>Am J
Epidemiol</em> 1998;147:914&#8211;20.</li>

<li class="Ref">Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with
supplemental calcium and other nutrients as factors affecting the risk for kidney stones in
women. <em>Ann Intern Med</em> 1997;126:497&#8211;504.</li>

<li class="Ref">Curhan GC, Willett WC, Speizer FE, Stampfer MJ. A prospective study of dietary
and supplemental calcium and the risk of kidney stones in women. <em>Am J Epidemiol</em>
1996;143(11Suppl):S15 [abstr #57].</li>

<li class="Ref">Pak CY. Nephrolithiasis from calcium supplementation. <em>J Urol</em>
1987;137:1212&#8211;3 [editorial].</li>

<li class="Ref">Levine BS, Rodman JS, Wienerman S, et al. Effect of calcium citrate
supplementation on urinary calcium oxalate saturation in female stone formers: implications
for prevention of osteoporosis. <em>Am J Clin Nutr</em> 1994;60:592&#8211;6.</li>

<li class="Ref">Pak CY, Sakhaee K, Hwang TIS, et al. Nephrolithiasis from calcium
supplementation. <em>J Urol</em> 1987;137:1212&#8211;3 [editorial/review].</li>

<li class="Ref">Bataille IP, Charransol G, Gregoire I, et al. Effect of calcium restriction on
renal excretion of oxalate and the probability of stones in the various pathophsiological
groups with calcium stones. <em>J Urol</em> 1983;130:218&#8211;23.</li>

<li class="Ref">Bataille P, Charransol G, Gregoire I, et al. Effect of calcium restriction on
renal excretion of oxalate and the probability of stones in the various pathophsiological
groups with calcium stones. <em>J Urol</em> 1983;130:218&#8211;23.</li>

<li class="Ref">Broadus AE, Insogna KL, Lang R, et al. Evidence for disordered control of
1,25-dihydroxyvitamin D production in absorptive hypercalciuria. <em>N Engl J Med</em>
1984;311:73&#8211;80.</li>

<li class="Ref">Netelenbos JC, Jongen MJM, van der Vijgh WJF, et al. Vitamin D status in
urinary calcium stone formation. <em>Arch Intern Med</em> 1985;145:681&#8211;4.</li>

<li class="Ref">Rao PN, Blacklock NJ. Hypercalciuria. <em>Lancet</em> 1983:ii:747
[letter].</li>

<li class="Ref">Nath R, Thind SK, Murthy MSR, et al. Role of pyridoxine in oxalate metabolism.
<em>Ann NY Acad Sci</em> 1990;585:274&#8211;84 [review].</li>

<li class="Ref">Watts RW, Veall N, Purkiss P, et al. The effect of pyridoxine on oxalate
dynamics in three cases of primary hyperoxaluria (with glycollic aciduria). <em>Clin Sci</em>
1985;69:87&#8211;90.</li>

<li class="Ref">Mitwalli A, Ayiomamitis W, Grass L, Oreopoulos DG. Control of hyperoxaluria
with large doses of pyridoxine in patients with kidney stones. <em>Int Urol Nephrol</em>
1988;20:353&#8211;9.</li>

<li class="Ref">Berkow R, Talbott JH, et al. <em>The Merck Manual of Diagnosis and
Therapy,</em> 13th ed. Rahway, NJ: Merck Sharp &amp; Dohme, 1977, 732.</li>

<li class="Ref">Gershoff SN, Prien EL. Effect of daily MgO and vitamin B6 administration to
patients with recurring calcium oxalate kidney stones. <em>Am J Clin Nutr</em>
1967;20(5)393&#8211;9.</li>

<li class="Ref">Prien EL, Gershoff SF. Magnesium oxide-pyridoxine therapy for recurrent
calcium oxalate calculi. <em>J Urol</em> 1974;112:509&#8211;12.</li>

<li class="Ref">Johansson G, Backman U, Danielson BG, et al. Effects of magnesium hydroxide in
renal stone disease. <em>J Am Coll Nutr</em> 1982;1:179&#8211;85.</li>

<li class="Ref">Gershoff SN, Prien EL. Effect of daily MgO and vitamin B6 administration to
patients with recurring calcium oxalate kidney stones. <em>Am J Clin Nutr</em>
1967;20(5)393&#8211;9.</li>

<li class="Ref">Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Intake of vitamins B6 and C
and the risk of kidney stones in women. <em>J Am Soc Nephrol</em> 1999;10:840&#8211;5.</li>

<li class="Ref">Ettiniger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium
oxalate calculus recurrence but magnesium hydroxide does not. <em>J Uro</em>l
1988;139:679&#8211;84.</li>

<li class="Ref">Prien EL, Gershoff SF. Magnesium oxide-pyridoxine therapy for recurrent
calcium oxalate calculi. <em>J Urol</em> 1974;112:509&#8211;12.</li>

<li class="Ref">Will EJ, Bijvoet OL. Primary oxalosis: clinical and biochemical response to
high-dose pyridoxine therapy. <em>Metabolism</em> 1979;28:542&#8211;8.</li>

<li class="Ref">Lindberg J, Harvey J, Pak CYC. Effect of magnesium citrate and magnesium oxide
on the crystallization of calcium salts in urine: changes produced by food-magnesium
interaction. <em>J Urol</em> 1990;143:248&#8211;51.</li>

<li class="Ref">Piesse JW. Nutritional factors in calcium containing kidney stones with
particular emphasis on vitamin C. <em>Int Clin Nutr Rev</em> 1985;5(3):110&#8211;29,
[review].</li>

<li class="Ref">Ringsdorf WM, Cheraskin WM. Medical complications from ascorbic acid: a review
and interpretation (part one). <em>J Holistic Med</em> 1984;6(1):49&#8211;63.</li>

<li class="Ref">Hoffer A. Ascorbic acid and kidney stones. <em>Can Med Assoc J</em>
1985;32:320 [letter].</li>

<li class="Ref">Wandzilak TR, D&#8217;Andre SD, Davis PA, Williams HE. Effect of high dose
vitamin C on urinary oxalate levels. <em>J Urol</em> 1994;151:834&#8211;7.</li>

<li class="Ref">Levine M. Vitamin C and optimal health. Presented at the February 25, 1999
60th Annual Biology Colloquium, Oregon State University, Corvallis, Oregon.</li>

<li class="Ref">Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in
healthy volunteers: evidence for a recommended dietary allowance. <em>Proc Natl Acad Sci U S
A</em> 1996;93:3704&#8211;9.</li>

<li class="Ref">Auer BL, Auer D, Rodgers AL. Relative hyperoxaluria, crystalluria and
haematuria after megadose ingestion of vitamin C. <em>Eur J Clin Invest</em>
1998;28:695&#8211;700.</li>

<li class="Ref">Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Intake of vitamins B6 and C
and the risk of kidney stones in women. <em>J Am Soc Nephrol</em> 1999;10:840&#8211;5.</li>

<li class="Ref">Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of the intake
of vitamins C and B6, and the risk of kidney stones in men. <em>J Urol</em>
1996;155:1847&#8211;51.</li>

<li class="Ref">Baggio B, Gambaro G, Marchini F, et al. Correction of erythrocyte
abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate
by oral glycosaminoglycans. <em>Lancet</em> 1991;338:403&#8211;5.</li>

<li class="Ref">Anbazhagan M, Hariprasad C, Amudram P, et al. Effect of oral supplementation
of vitamin E on urinary risk factors in patients with hyperoxaluria. <em>J Clin Biochem
Nutr</em> 1999;27:37&#8211;47.</li>

<li class="Ref">Suphakarn VS, Yarnnon C, Ngunboonsri P. The effect of pumpkin seeds on
oxalcrystalluria and urinary compositions of children in hyperendemic area. <em>Am J Clin
Nutr</em> 1987;45:115&#8211;21.</li>

<li class="Ref">Suphiphat V, Morjaroen N, Pukboonme I, et al. The effect of pumpkin seeds
snack on inhibitors and promoters of urolithiasis in Thai adolescents. <em>J Med Assoc
Thai</em> 1993;76:487&#8211;93.</li>

<li class="Ref">Suphakarn VS, Yarnnon C, Ngunboonsri P. The effect of pumpkin seeds on
oxalcrystalluria and urinary compositions of children in hyperendemic area. <em>Am J Clin
Nutr</em> 1987;45:115&#8211;21.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Kidney_Stones.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:30 GMT -->
</html>

